Head-to-head · WeighScore
Nouri vs Ozari Health
The verdict
Ozari Health takes it — 68.9/100 to 54.8/100.
Ozari Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ozari Health is a telehealth weight-loss platform selling physician-prescribed compounded GLP-1 from licensed 503A/503B pharmacies.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Nouri | Ozari Health |
|---|---|---|
| WeighScore | 54.8/100 | 68.9/100 |
| Grade | C | C |
| Scorecard rank | #454 | #136 |
| Semaglutide | Not disclosed | $86/mo (3-mo starter plan, new patients only, compounded) |
| Tirzepatide | Not disclosed | $125/mo (3-mo starter plan, new patients only, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #454 · C
Strengths
- Named clinical MSO partner (Wasef Health, PC; Michael Wasef, MD) with public contact email
- Named 503A compounding pharmacy partner (Jungle Jim's Pharmacy, Fairfield OH) with full address
- Available in all 50 states per the FAQ
- Flat per-dose pricing within each tier — no dose-escalation surcharge
- Nutrition and movement coaching included in the medication price
Where it loses points
- Compounded medications only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
- Operating entity name not disclosed in the Terms of Service
- Terms 'where we operate' language is slightly weaker than the FAQ's all-50-states claim
- Video visit required in some states, but those states aren't listed
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #136 · C
Strengths
- Very low entry pricing — compounded semaglutide from $86/month
- LegitScript certified and operated by a named entity (Ozari LLC)
- Board-certified physicians; meds compounded in 503A and 503B facilities
- Shipping included in the plan price
Where it loses points
- The advertised rates are three-month starter plans for first-time GLP-1 users, billed $257 and $375 up front; month-to-month is $175 and $235
- Cancelling an annual or semi-annual plan early re-prices the installments already shipped at the standard monthly rate and charges the difference
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.